Lisa L.Furby

Lisa Furby practices in the area of intellectual property law, with an emphasis on patent litigation. She has experience in all phases of litigation, including written discovery, fact and expert depositions testimony, claim construction, summary judgment, trial, post-trial motions, and appeals. Lisa has represented clients in district courts across the country and before the U.S. Court of Appeals for the Federal Circuit as well as before the International Trade Commission and the Patent Trial and Appeal Board. She represents a broad range of clients, including those in the automotive and pharmaceutical industries.

In 2016, Lisa was a member of the trial team that achieved the record-breaking patent infringement verdict for Idenix Pharmaceuticals (a subsidiary of Merck & Co.), the largest infringement verdict in U.S. history. After a two-week trial, the jury ordered Gilead Sciences to pay $2.54 billion in damages for sales of sofosbuvir-based medicines, including Sovaldi and Harvoni, for its infringement of an Idenix patent related to the treatment of patients with hepatitis C virus (HCV) infection.

Lisa also maintains an active pro bono practice and has represented multiple clients seeking asylum in immigration proceedings as part of the Firm's Laredo Project.